Evidence map›Paper›PMID 26112360›Full record

Trial reportRadiation oncology (London, England)2015

Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors.

Jeonghoon Park, Younghee Park, Sung Uk Lee, Taeyoon Kim, Yun-Kyung Choi, Joo-Young Kim

Open access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Radiation oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Cytotoxic Activity of Antineoplastic Agents on Fertility: A Systematic Review.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Signaling pathways in brain tumors and therapeutic interventions.Signal transduction and targeted therapy · 2023
    Review
  8. Review
  9. Benign and Malignant Tumors of the Pineal Region.Advances in experimental medicine and biology · 2023
    Article
  10. Pineal germinoma in a young adult: A case report.Cancer reports (Hoboken, N.J.) · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. A single-center study of treatment outcomes of pediatric basal ganglia germinoma in Taiwan.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  18. Article
  19. Proton Beam Therapy for Pediatric Brain Tumor.Neurologia medico-chirurgica · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jeonghoon ParkCenter for Proton Therapy, Goyang-si, Republic of Korea. jhoon@ncc.re.kr.
Younghee ParkDepartment of Radiation Oncology, Soonchunhyang University Hospital, Seoul, Republic of Korea. yh810530@hanmail.net.
Sung Uk LeeCenter for Proton Therapy, Goyang-si, Republic of Korea. sung-uk.lee@ncc.re.kr.
Taeyoon KimCenter for Proton Therapy, Goyang-si, Republic of Korea. tykim@ncc.re.kr.
Yun-Kyung ChoiCenter for Proton Therapy, Goyang-si, Republic of Korea. jewel@ncc.re.kr.
Joo-Young KimCenter for Proton Therapy, Goyang-si, Republic of Korea. jooyoungcasa@ncc.re.kr.
National Cancer Center · KRSoonchunhyang University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed dosimetric comparisons between proton beam therapy and intensity modulated radiotherapy (IMRT) of intracranial germ cell tumors (ICGCTs) arising in various locations of the brain. MATERIALS: IMRT, passively scattered proton therapy (PSPT), and spot scanning proton therapy (SSPT) plans were performed for four different target volumes: the whole ventricle (WV), pineal gland (PG), suprasellar (SS), and basal ganglia (BG). Five consecutive clinical cases were selected from the patients treated between 2011 and 2014 for each target volume. Total 20 cases from the 17 patients were included in the analyses with three overlap cases which were used in plan comparison both for the whole ventricle and boost targets. The conformity index, homogeneity index, gradient index, plan quality index (PQI), and doses applied to the normal substructures of the brain were calculated for each treatment plan.

resultsThe PQI was significantly superior for PSPT and SSPT than IMRT for ICGCTs in all locations (median; WV: 2.89 and 2.37 vs 4.06, PG: 3.38 and 2.70 vs 4.39, SS: 3.92 and 2.49 vs 4.46, BG: 3.01 and 2.49 vs 4.45). PSPT and SSPT significantly reduced the mean dose, and the 10 and 15 Gy dose volumes applied to the normal brain compared with IMRT (p ≤ 0.05). PSPT and SSPT saved significantly greater volumes of the temporal lobes and hippocampi (p < 0.05) in the SS and PG targets than IMRT. For tumors arising in the BG, PSPT and SSPT also saved greater volumes of the contralateral temporal lobes.

conclusionsPSPT and SSPT provide superior target volume coverage and saved more normal tissue compared with IMRT for ICGCTs in various locations. Future studies should assess whether the extent of normal tissue saved has clinical benefits in children with ICGCTs.

Indexed as

AdolescentAntineoplastic Combined Chemotherapy ProtocolsBasal GangliaBrain NeoplasmsChildChild, PreschoolCombined Modality TherapyFemaleGerminomaHumansInfantMaleNeoplasms, Germ Cell and EmbryonalOrgan Sparing TreatmentsPineal GlandPituitary Neoplasms

Identifiers

PMID26112360
PMCPMC4480576
OpenAlexW2148530348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.